---
title: "ASTRAPHARM — Ownership Dossier"
canonical: https://whiteintel.dev/entity/111cbdcc-95d0-5e53-bac3-0aa9320e2af4
json: https://whiteintel.dev/api/public/dossier/111cbdcc-95d0-5e53-bac3-0aa9320e2af4
identifier: oo:GB-COH-00519037
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# ASTRAPHARM

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-00519037`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/111cbdcc-95d0-5e53-bac3-0aa9320e2af4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/111cbdcc-95d0-5e53-bac3-0aa9320e2af4  

## Ownership & control

### Owners / controllers

- **ASTRAZENECA TREASURY LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff
- **ASTRAZENECA TREASURY LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff

### UBO chain (walk to the ultimate owner)

A **10-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `00519037`
- **Status:** active
- **Type:** private unlimited
- **Incorporated:** 1953-04-25
- **Registered office:** 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
- **SIC:** 74990

### Officers

- JOHNSTONE, Camilla Jane — secretary · appointed 2019-07-31
- BOWDEN, Matthew Shaun — director · British · appointed 2019-02-27
- COLLINS, Iain Alistair — director · British · appointed 2017-05-31
- TATTERSALL, Hannah Victoria — director · British · appointed 2025-05-01
- BACHE, David Colin — secretary · British · appointed 1998-06-29 · resigned 2000-11-10
- CONACHER, Matthew Ian — secretary · appointed 2017-03-16 · resigned 2019-07-31
- LACHLAN, Cacilia Maria — secretary · British · appointed 2000-11-10 · resigned 2011-03-31
- TALIADOROS, Kim Jehan — secretary · appointed 2011-03-31 · resigned 2016-09-21
- VIGART, Nicholas Peter — secretary · British · resigned 1998-05-14
- BANKS, Caroline Mary — director · British · appointed 2000-01-04 · resigned 2000-11-09
- BRIMICOMBE, Ian Martin David — director · British · appointed 2000-11-09 · resigned 2017-05-31
- FEULNER, Andreas — director · German · appointed 1992-11-20 · resigned 1994-03-14
- GRADY, Shaun Francis — director · British · appointed 2000-01-04 · resigned 2004-11-01
- HOSKINS, Justin Wilbert — director · British · appointed 2006-11-20 · resigned 2012-01-10
- JACKSON-TURNER, Katie Louise — director · British · appointed 2015-07-15 · resigned 2019-02-27
- KELLY, Linda Mary — director · British · appointed 1995-05-30 · resigned 2000-01-05
- KEMP, Adrian Charles Noel — director · British · appointed 2017-03-16 · resigned 2025-05-01
- KEMP, Adrian Charles Noel — director · British · appointed 2003-10-10 · resigned 2006-11-20
- KIRBY, Pamela Josephine, Dr — director · British · resigned 1996-08-14
- O'GRADY, Claire-Marie — director · British · appointed 2012-01-10 · resigned 2015-07-31

### Beneficial owners (Persons with Significant Control)

- [Astrazeneca Treasury Limited](https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff) — 75–100% shares · corporate PSC · United Kingdom — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/00519037
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/00519037

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **ASTRAPHARM** — https://whiteintel.dev/entity/111cbdcc-95d0-5e53-bac3-0aa9320e2af4 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **ASTRAPHARM**. Human view: https://whiteintel.dev/entity/111cbdcc-95d0-5e53-bac3-0aa9320e2af4 · Structured JSON: https://whiteintel.dev/api/public/dossier/111cbdcc-95d0-5e53-bac3-0aa9320e2af4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._